BioCentury
ARTICLE | Company News

Tesaro rises on takeout rumors

February 8, 2017 10:48 PM UTC

Tesaro Inc. (NASDAQ:TSRO) jumped $19.73 (12%) to $182.68 on Wednesday after media reports said the company was in discussions with investment banks about a possible acquisition by multiple biopharmas. Tesaro spokesperson Jennifer Davis declined to comment.

Investors have identified Tesaro as a likely M&A target (see BioCentury, Jan. 2)...

BCIQ Company Profiles

Tesaro Inc.